Abstract:OBJECTIVE:To investigate the incidence rate and risk factors for metabolic bone disease of prematurity (MBDP) in very low birth weight/extremely low birth weight (VLBW/ELBW) infants.METHODS:The medical data of 61 786 neonates from multiple centers of China between September 1, 2013 and August 31, 2016 were retrospectively investigated, including 504 VLBW/ELBW preterm infants who met the inclusion criteria. Among the 504 infants, 108 infants diagnosed with MBDP were enrolled as the MBDP group and the remaining 396 infants were enrolled as the non-MBDP group. The two groups were compared in terms of general information of mothers and preterm infants, major diseases during hospitalization, nutritional support strategies, and other treatment conditions. The multivariate logistic regression analysis was used to investigate the risk factors for MBDP.RESULTS:The incidence rate of MBDP was 19.4% (88/452) in VLBW preterm infants and 38.5% (20/52) in ELBW preterm infants. The incidence rate of MBDP was 21.7% in preterm infants with a gestational age of < 32 weeks and 45.5% in those with a gestational age of < 28 weeks. The univariate analysis showed that compared with the non-MBDP group, the MBDP group had significantly lower gestational age and birth weight, a significantly longer length of hospital stay, and a significantly higher incidence rate of extrauterine growth retardation (P < 0.05). Compared with the non-MBDP group, the MBDP group had significantly higher incidence rates of neonatal sepsis, anemia, hypocalcemia, and retinopathy of prematurity (P < 0.05). The MBDP group had a significantly lower mean feeding speed, a significantly higher age when reaching total enteral feeding, and a significantly longer duration of parenteral nutrition (P < 0.05). The use rate of caffeine citrate in the MBDP group was significantly higher, but the use rate of erythropoietin was significantly lower than that in the non-MBDP group (P < 0.05). The multivariate logistic regression analysis showed that gestational age < 32 weeks, hypocalcemia, extrauterine growth retardation at discharge, and neonatal sepsis were risk factors for MBDP (P < 0.05).CONCLUSIONS:A lower gestational age, hypocalcemia, extrauterine growth retardation at discharge, and neonatal sepsis may be associated an increased risk of MBDP in VLBW/ELBW preterm infants. It is necessary to strengthen perinatal healthcare, avoid premature delivery, improve the awareness of the prevention and treatment of MBDP among neonatal pediatricians, and adopt positive and reasonable nutrition strategies and comprehensive management measures for preterm infants.

Metabolic Bone Disease of Prematurity: Diagnosis and Management

Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences

Metabolic Bone Disease in Premature Neonates: An Unmet Challenge

Invited Mini Review Metabolic Bone Disease of Prematurity: Overview and Practice Recommendations

[Risk Factors for Metabolic Bone Disease of Prematurity in Very/extremely Low Birth Weight Infants: a Multicenter Investigation in China].

Outcomes of standardised approach to metabolic bone disease of prematurity

Expert consensus on clinical management of metabolic bone disease of prematurity (2021)

Analysis of clinical risk factors for metabolic bone disease of prematurity

High-risk factors for metabolic bone disease in very low birth weight infants: a multicentre retrospective study

Metabolic bone disease of prematurity screening and individualized enteral mineral supplementation in high-risk neonates: a quality improvement initiative

Role of fibroblast growth factor-23 as an early marker of metabolic bone disease of prematurity

Screening of Serum Alkaline Phosphatase and Phosphate Helps Early Detection of Metabolic Bone Disease in Extremely Low Birth Weight Infants

[CA, P, AND MG POSTNATAL METABOLISM AND REQUIREMENTS IN PARENTERAL AND ENTERAL NUTRITION OF PREMATURE INFANTS].

The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants

Neurodevelopment Outcomes in Very-Low-Birth-Weight Infants with Metabolic Bone Disease at 2 Years of Age

Risk factors for metabolic bone disease (osteopenia of prematurity) in preterm infants with very low and extremely low birth weight

[Hypophosphatemia in preterm infants: a bimodal disorder]

Biomarkers and Biochemical Indicators to Evaluate Bone Metabolism in Preterm Neonates

Prediction of bone metabolism disorders in premature babies

Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce

Effect of early preventive supplementation with calcium and phosphorus on metabolic bone disease in premature infants